about
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-cau...
Read More
8.30
0.01
(0.12%)
639.8K
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Low Financial Strength
Mid Valuation
Technically Bearish
Weak Stock
These stocks have weak financials and momentum. Buying interest is low. While the stock is affordable, investors should exercise caution
View Similar
Embed DVM
Arvinas Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..